# Disc Medicine, Inc. Common Stock (IRON) FDA rejects Disc Medicine's bitopertin drug despite expedited review, causing shares to tank. Analysts remain divided, with some seeing a buying opportunity while others highlight regulatory uncertainty. ### About Disc Medicine, Inc. Common Stock Disc Medicine, Inc. Common Stock (IRON) is a publicly traded stock in the healthcare sector focused on drug development. Disc Medicine, Inc. Common Stock uses the ticker $IRON for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Disc Medicine, Inc. Common Stock (IRON) social dominance hit [------] which is 151% higher than it's daily average. - Disc Medicine, Inc. Common Stock (IRON) mentions hit [---] which is 144% higher than it's daily average. - Disc Medicine, Inc. Common Stock (IRON) creators hit [---] which is 177% higher than it's daily average. - Disc Medicine, Inc. Common Stock (IRON) trading volume is up 135.23% from the previous week. - Disc Medicine, Inc. Common Stock (IRON) social dominance is up 4273.08% from the previous week. - Disc Medicine, Inc. Common Stock (IRON) creators is up 68.45% from the previous week. - Disc Medicine, Inc. Common Stock (IRON) engagements is up 630.53% from the previous week. - Disc Medicine, Inc. Common Stock (IRON) mentions is up 67.69% from the previous week. - Disc Medicine, Inc. Common Stock (IRON) posts created is up 485% from the previous week. - Disc Medicine, Inc. Common Stock Engagements hit a 52-Week high of [-------] for the day ### Price: $56  [Price 24-Hour Time-Series Raw Data](/topic/$iron/time-series/close.tsv) The price of IRON has seen a significant drop following the FDA's Complete Response Letter for bitopertin, despite previous recognition as a top gainer. This rejection, coupled with a shrinking social community, is likely driving the negative price action. 24-Hour: -18.48% 7-Day: -29.82% 30-Day: -21.12% 1-Year High: $94.10 on 2025-11-24 1-Year Low: $34.30 on 2025-04-08 ### AltRank: [---]  [AltRank 24-Hour Time-Series Raw Data](/topic/$iron/time-series/alt_rank.tsv) Disc Medicine, Inc. Common Stock (IRON) is currently AltRank #565 based on combined combined social and market metrics Daily Average: [---] [--] Week: [---] [----] [--] Month: [---] +179 [--] Months: [---] +72 [--] Year: [---] [----] 1-Year High: [-----] on 2026-02-02 1-Year Low: [--] on 2025-10-18 ### Galaxy Score: [-----]  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/$iron/time-series/galaxy_score.tsv) Current Value: [-----] Daily Average: [--] [--] Week: [--] [---] [--] Month: [--] [---] 1-Year High: [--] on 2025-10-20 1-Year Low: [--] on 2025-11-27 ### Engagements: [------] (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/$iron/time-series/interactions.tsv) Current Value: [------] Daily Average: [-----] [--] Week: [-------] +631% [--] Month: [-------] +258% [--] Months: [---------] +88% [--] Year: [---------] -53% 1-Year High: [-------] on 2026-02-13 1-Year Low: [---] on 2025-09-14 Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [-----] X: [------] ### Mentions: [---] (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/$iron/time-series/posts_active.tsv) Current Value: [---] Daily Average: [---] [--] Week: [---] +68% [--] Month: [---] +33% [--] Months: [-----] +86% [--] Year: [-----] +19% 1-Year High: [---] on 2025-10-21 1-Year Low: [--] on 2025-09-14 Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [--] X: [---] ### Creators: [---] (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/$iron/time-series/contributors_active.tsv) [---] unique social accounts have posts mentioning Disc Medicine, Inc. Common Stock (IRON) in the last [--] hours which is up 8.90% from [---] in the previous [--] hours Daily Average: [--] [--] Week: [---] +68% [--] Month: [---] +24% [--] Months: [-----] +47% [--] Year: [-----] +95% 1-Year High: [---] on 2025-10-21 1-Year Low: [--] on 2025-09-19 The most influential creators that mention Disc Medicine, Inc. Common Stock in the last [--] hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@RNAiAnalyst](/creator/twitter/RNAiAnalyst) | [--] | [------] | [--] | [-----] | | [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | [--] | [-----] | [--] | [-----] | | [@TimCarmichael3](/creator/twitter/TimCarmichael3) | [--] | [-----] | [--] | [---] | | [@BPharmCatalyst](/creator/twitter/BPharmCatalyst) | [--] | [------] | [--] | [---] | | [@stocktreats](/creator/twitter/stocktreats) | [--] | [-----] | [--] | [---] | | [@MarcJacksonLA](/creator/twitter/MarcJacksonLA) | [--] | [-----] | [--] | [---] | | [@notreload_ai](/creator/twitter/notreload_ai) | [--] | [-----] | [--] | [---] | | [@Pharmdca](/creator/twitter/Pharmdca) | [--] | [-------] | [--] | [---] | | [@Tautilas](/creator/twitter/Tautilas) | [--] | [-----] | [--] | [--] | | [@SpikeRadar](/creator/twitter/SpikeRadar) | [--] | [--] | [--] | [--] | [View More](/list/creators/$iron/100) ### Sentiment: 33%  [Sentiment 24-Hour Time-Series Raw Data](/topic/$iron/time-series/sentiment.tsv) Current Value: 33% Daily Average: 53% [--] Week: 50% -30% [--] Month: 35% -2% [--] Months: 35% -19% [--] Year: 35% -51% 1-Year High: 100% on 2025-02-28 1-Year Low: 13% on 2025-12-23 Most Supportive Themes: - Wrapped IRON (wIRON) Launch: (30%) The launch of wIRON on the Base chain is generating positive attention. - Top Gainer Recognition: (15%) Mentions of $IRON as a top gainer on platforms like Coinstore are drawing positive attention. Most Critical Themes: - Shrinking Social Community: (50%) The social community surrounding IRON is showing signs of shrinkage, which could negatively impact its value. - Negative Sentiment Impact: (5%) Negative sentiment is currently affecting the community's outlook on IRON. ### Social Dominance: 0.017%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/$iron/time-series/social_dominance.tsv) Current Value: 0.017% Daily Average: 0.013% [--] Week: 0.114% +0.111% [--] Month: 0.033% +0.013% [--] Months: 0.033% +0.025% [--] Year: 0.033% +0.024% 1-Year High: 0.044% on 2025-10-21 1-Year Low: 0.0015% on 2025-09-19 ### Market Dominance: 0.0025%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/$iron/time-series/market_dominance.tsv) Current Value: 0.0025% Daily Average: 0% 1-Year High: 0.139% on 2026-02-06 1-Year Low: 0.0025% on 2026-02-14 ### Market Cap: $2,204,609,461  [Market Cap 24-Hour Time-Series Raw Data](/topic/$iron/time-series/market_cap.tsv) Current Value: $2,204,609,461 Daily Average: $3,107,506,286 [--] Week: $2,204,986,962 -27% [--] Month: $2,112,121,564 -21% 1-Year High: $3,552,667,746 on 2025-11-24 1-Year Low: $2,112,121,564 on 2026-02-13 ### Top Disc Medicine, Inc. Common Stock Social Posts Top posts by engagements in the last [--] hours *Showing a maximum of [--] top social posts without a LunarCrush subscription.* "Disc gets FDA snub for Commissioner voucher-backed bitopertin $IRON https://firstwordpharma.com/story/7104609 https://firstwordpharma.com/story/7104609" [X Link](https://x.com/fwpharma/status/2022860327583367362) [@fwpharma](/creator/x/fwpharma) 2026-02-15T02:27Z 55.2K followers, [---] engagements "$IRON Truist Bottom-line: CRL while disappointing is not the end of the world for IRON. The full Phase [--] readout is expected in 4Q and we remain optimistic given the learnings and refinements applied following the Phase [--]. Even if investors were to strip out all value for bitopertin we still estimate IRON shares are worth roughly $45$55 based on [----] and cash alone. https://twitter.com/i/web/status/2022799298279145678 https://twitter.com/i/web/status/2022799298279145678" [X Link](https://x.com/semodough/status/2022799298279145678) [@semodough](/creator/x/semodough) 2026-02-14T22:25Z 42.5K followers, [----] engagements "π $OBAI- $LIMN- $IRON ππΈπΈπΈ #_ #_ #" [X Link](https://x.com/ahelaahela23/status/2022727274953355508) [@ahelaahela23](/creator/x/ahelaahela23) 2026-02-14T17:38Z [--] followers, [---] engagements "I don't get why people is "annoyed" with $IRON CRL. "The CNPV is an FDA initiative aimed at dramatically reducing review times to [--] months for drugs and biologics that support U.S. national health interests" CNPV reduces review time it does not mean higher % of approval" [X Link](https://x.com/Investorclimber/status/2022725430856315015) [@Investorclimber](/creator/x/Investorclimber) 2026-02-14T17:31Z [---] followers, [---] engagements Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
FDA rejects Disc Medicine's bitopertin drug despite expedited review, causing shares to tank. Analysts remain divided, with some seeing a buying opportunity while others highlight regulatory uncertainty.
Disc Medicine, Inc. Common Stock (IRON) is a publicly traded stock in the healthcare sector focused on drug development.
Disc Medicine, Inc. Common Stock uses the ticker $IRON for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The price of IRON has seen a significant drop following the FDA's Complete Response Letter for bitopertin, despite previous recognition as a top gainer. This rejection, coupled with a shrinking social community, is likely driving the negative price action.
24-Hour: -18.48% 7-Day: -29.82% 30-Day: -21.12%
1-Year High: $94.10 on 2025-11-24
1-Year Low: $34.30 on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Disc Medicine, Inc. Common Stock (IRON) is currently AltRank #565 based on combined combined social and market metrics
Daily Average: [---]
[--] Week: [---] [----]
[--] Month: [---] +179
[--] Months: [---] +72
[--] Year: [---] [----]
1-Year High: [-----] on 2026-02-02
1-Year Low: [--] on 2025-10-18
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] [---]
[--] Month: [--] [---]
1-Year High: [--] on 2025-10-20
1-Year Low: [--] on 2025-11-27
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [-----]
[--] Week: [-------] +631%
[--] Month: [-------] +258%
[--] Months: [---------] +88%
[--] Year: [---------] -53%
1-Year High: [-------] on 2026-02-13
1-Year Low: [---] on 2025-09-14
Engagements by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [-----] X: [------]
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +68%
[--] Month: [---] +33%
[--] Months: [-----] +86%
[--] Year: [-----] +19%
1-Year High: [---] on 2025-10-21
1-Year Low: [--] on 2025-09-14
Mentions by network (24h): News: [--] Reddit: [--] TikTok: [--] YouTube: [--] X: [---]
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Disc Medicine, Inc. Common Stock (IRON) in the last [--] hours which is up 8.90% from [---] in the previous [--] hours
Daily Average: [--]
[--] Week: [---] +68%
[--] Month: [---] +24%
[--] Months: [-----] +47%
[--] Year: [-----] +95%
1-Year High: [---] on 2025-10-21
1-Year Low: [--] on 2025-09-19
The most influential creators that mention Disc Medicine, Inc. Common Stock in the last [--] hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @RNAiAnalyst | [--] | [------] | [--] | [-----] |
| @BiotechAnalysst | [--] | [-----] | [--] | [-----] |
| @TimCarmichael3 | [--] | [-----] | [--] | [---] |
| @BPharmCatalyst | [--] | [------] | [--] | [---] |
| @stocktreats | [--] | [-----] | [--] | [---] |
| @MarcJacksonLA | [--] | [-----] | [--] | [---] |
| @notreload_ai | [--] | [-----] | [--] | [---] |
| @Pharmdca | [--] | [-------] | [--] | [---] |
| @Tautilas | [--] | [-----] | [--] | [--] |
| @SpikeRadar | [--] | [--] | [--] | [--] |
Sentiment 24-Hour Time-Series Raw Data
Current Value: 33%
Daily Average: 53%
[--] Week: 50% -30%
[--] Month: 35% -2%
[--] Months: 35% -19%
[--] Year: 35% -51%
1-Year High: 100% on 2025-02-28
1-Year Low: 13% on 2025-12-23
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.017%
Daily Average: 0.013%
[--] Week: 0.114% +0.111%
[--] Month: 0.033% +0.013%
[--] Months: 0.033% +0.025%
[--] Year: 0.033% +0.024%
1-Year High: 0.044% on 2025-10-21
1-Year Low: 0.0015% on 2025-09-19
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.0025%
Daily Average: 0%
1-Year High: 0.139% on 2026-02-06
1-Year Low: 0.0025% on 2026-02-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $2,204,609,461
Daily Average: $3,107,506,286
[--] Week: $2,204,986,962 -27%
[--] Month: $2,112,121,564 -21%
1-Year High: $3,552,667,746 on 2025-11-24
1-Year Low: $2,112,121,564 on 2026-02-13
Top posts by engagements in the last [--] hours
Showing a maximum of [--] top social posts without a LunarCrush subscription.
"Disc gets FDA snub for Commissioner voucher-backed bitopertin $IRON https://firstwordpharma.com/story/7104609 https://firstwordpharma.com/story/7104609"
X Link @fwpharma 2026-02-15T02:27Z 55.2K followers, [---] engagements
"$IRON Truist Bottom-line: CRL while disappointing is not the end of the world for IRON. The full Phase [--] readout is expected in 4Q and we remain optimistic given the learnings and refinements applied following the Phase [--]. Even if investors were to strip out all value for bitopertin we still estimate IRON shares are worth roughly $45$55 based on [----] and cash alone. https://twitter.com/i/web/status/2022799298279145678 https://twitter.com/i/web/status/2022799298279145678"
X Link @semodough 2026-02-14T22:25Z 42.5K followers, [----] engagements
"π $OBAI- $LIMN- $IRON ππΈπΈπΈ #_ #_ #"
X Link @ahelaahela23 2026-02-14T17:38Z [--] followers, [---] engagements
"I don't get why people is "annoyed" with $IRON CRL. "The CNPV is an FDA initiative aimed at dramatically reducing review times to [--] months for drugs and biologics that support U.S. national health interests" CNPV reduces review time it does not mean higher % of approval"
X Link @Investorclimber 2026-02-14T17:31Z [---] followers, [---] engagements
Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing
/topic/$iron